Når Tasmar gives som tillægsbehandling til den Parkinson- medicin, patienterne får i forvejen, skal de gøres opmærksom på, at de kan få nogle af bivirkningerne ved levodopa, men at dette ofte kan afhjælpes ved at mindske levodopa- dosis.
When patients add Tasmar to their exiting anti-Parkinson’ s disease medication, they need to be made aware that they may experience some of the side effects of levodopa although these can often be reduced by lowering the dose of levodopa.